title: Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients.
authors.affiliation: Department of Surgery, McGill University, Montreal, Canada.
authors.forename: J I
authors.initials: JI
authors.lastname: Tchervenkov
authors.forename: A J
authors.initials: AJ
authors.lastname: Tector
authors.forename: M
authors.initials: M
authors.lastname: Cantarovich
authors.forename: S A
authors.initials: SA
authors.lastname: Tahta
authors.forename: A
authors.initials: A
authors.lastname: Asfar
authors.forename: J
authors.initials: J
authors.lastname: Naimi
authors.forename: N
authors.initials: N
authors.lastname: Elias
authors.forename: J
authors.initials: J
authors.lastname: Barkun
mesh_terms: D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D015996:Survival Rate; D013997:Time Factors
chemical_list: D001786:Blood Glucose; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin